| HOME >> BIOLOGY >> TECHNOLOGY |
Warrants liability 2,492 -
Total current liabilities 11,318 11,755
Debt, less current portion 6,342 5,754
Deferred rent 15,415 10,145
Commitments and contingencies
Stockholders' equity:
Preferred stock, $0.001 par value 5,000,000
shares authorized; no shares issued
and outstanding at December 31, 2007 and 2006,
respectively - -
Common stock, $0.001 par value 75,000,000
shares authorized; 41,168,432 and 29,060,081
issued and outstanding at December 31, 2007
and 2006, respectively 41 29
Additional paid-in capital 233,807 200,497
Accumulated other comprehensive income 7 3
Deficit accumulated during the development
stage (198,975) (155,894)
Total stockholders' equity 34,880 44,635
Total liabilities and stockholders' equity $67,955 $72,289
FAVRILLE, INC.
(a development stage company)
STATEMENTS OF OPERATIONS
(in thousands, except share and per share data)
Three months ended
Years ended December 31, December 31,
2007 2006 2007 2006
(unaudited) (unaudited) (unaudited)
Operating expenses:
Research &
development $34,864 $31,050 $7,764 $7,680
<| SOURCE Favrille, Inc. Copyright©2008 PR Newswire. All rights reserved |